Topical corticosteroid eye drop is the mainstay for preventing and treating corneal graft
rejection. While the frequent topical corticosteroid use is associated with risk of intraocular …

Immunologic graft rejection is one of the main causes of short and long-term graft failure in
corneal transplantation. Steroids are the most commonly used immunosuppressive agents …

Frequent and long-term use of topical corticosteroids after corneal transplantation is
necessary to prevent graft rejection. However, it relies heavily on patient compliance, and …

Corneal neovascularization (CNV) leads to the loss of corneal transparency and vision
impairment, and can ultimately cause blindness. Topical corticosteroids are the first line …

Purpose Oral cyclosporin A used in addition to high-dose intravenous pulse
methylprednisolone has been shown to have an adjunctive effect in reversing the rejection …

We evaluated whether corneal graft survival in presensitized corneal transplantation was
affected by subconjunctival ranibizumab in a rat model. The effect of ranibizumab in the …

Management of Corneal Graft Rejection – A Case Series Report and Review of the Literature -
PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …

In 2000, nearly 47,000 corneal transplantations were performed in the United States, making
penetrating keratoplasty one of the most common human tissue transplantation procedures …

Purpose: To analyze current practice patterns in the prevention and treatment of corneal
graft rejection for both penetrating keratoplasty (PK) and endothelial keratoplasty (EK) and to …

We tested the ability of 15-deoxyspergualin (DSG), a new immunosuppressant, to inhibit
corneal allograft rejection in the rat penetrating keratoplasty model. Fifty-six inbred Lewis …